202 related articles for article (PubMed ID: 10834852)
1. Anti-TNFalpha: a new dimension in the pharmacotherapy of the spondyloarthropathies !?
Braun J; Sieper J
Ann Rheum Dis; 2000 Jun; 59(6):404-7. PubMed ID: 10834852
[No Abstract] [Full Text] [Related]
2. New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti-tumor necrosis factor therapy.
Braun J; de Keyser F; Brandt J; Mielants H; Sieper J; Veys E
Curr Opin Rheumatol; 2001 Jul; 13(4):245-9. PubMed ID: 11555723
[TBL] [Abstract][Full Text] [Related]
3. Infliximab treatment for rheumatic disease: clinical and radiological efficacy.
St Clair EW
Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii67-9. PubMed ID: 12379627
[TBL] [Abstract][Full Text] [Related]
4. Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update.
Pham T; Fautrel B; Dernis E; Goupille P; Guillemin F; Le Loët X; Ravaud P; Claudepierre P; Miceli-Richard C; de Bandt M; Breban M; Maillefert JF; Masson C; Saraux A; Schaeverbeke T; Wendling D; Mariette X; Combe B;
Joint Bone Spine; 2007 Dec; 74(6):638-46. PubMed ID: 18065252
[TBL] [Abstract][Full Text] [Related]
5. [Anti-TNF-alpha treatment and spondyloarthropathies].
Braun Y; Balbir-Gurman A
Harefuah; 2002 Nov; 141(11):965-8, 1010. PubMed ID: 12476631
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of infliximab (Remicade) in the treatment of spondyloarthropathies. two case reports.
Kaiser MJ; Sany J
Joint Bone Spine; 2001 Dec; 68(6):525-7. PubMed ID: 11808993
[No Abstract] [Full Text] [Related]
7. Update on anti-tumor necrosis factor therapy in the spondyloarthropathies including psoriatic arthritis.
Kavanaugh A; Tutuncu Z; Catalan-Sanchez T
Curr Opin Rheumatol; 2006 Jul; 18(4):347-53. PubMed ID: 16763453
[TBL] [Abstract][Full Text] [Related]
8. Switching tumour necrosis factor alpha antagonists in patients with ankylosing spondylitis and psoriatic arthritis: an observational study over a 5-year period.
Conti F; Ceccarelli F; Marocchi E; Magrini L; Spinelli FR; Spadaro A; Scrivo R; Valesini G
Ann Rheum Dis; 2007 Oct; 66(10):1393-7. PubMed ID: 17613555
[TBL] [Abstract][Full Text] [Related]
9. Psoriasis onset during infliximab treatment: description of two cases.
Volpe A; Caramaschi P; Carletto A; Pieropan S; Bambara LM; Biasi D
Rheumatol Int; 2006 Oct; 26(12):1158-60. PubMed ID: 16738903
[TBL] [Abstract][Full Text] [Related]
10. Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
Rossini M; Viapiana O; Orsolini G; Fracassi E; Idolazzi L; Gatti D; Adami S; Govoni M
Reumatismo; 2015 Mar; 66(4):285-303. PubMed ID: 25829189
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tumour necrosis factor-alpha in patients with chronic hepatitis C infection.
Zavos C; Kountouras J; Zavos N; Chatzopoulos D
Clin Rheumatol; 2007 Feb; 26(2):283. PubMed ID: 17003955
[No Abstract] [Full Text] [Related]
12. Do TNF-blockers reduce or induce uveitis?
Cobo-Ibáñez T; del Carmen Ordóñez M; Muñoz-Fernández S; Madero-Prado R; Martín-Mola E
Rheumatology (Oxford); 2008 May; 47(5):731-2. PubMed ID: 18346974
[No Abstract] [Full Text] [Related]
13. [Treatment outcome of spondyloarthropathy with infliximab].
Głowska A; Wiland P; Szechiński J
Pol Arch Med Wewn; 2005 Jan; 113(1):42-7. PubMed ID: 16130600
[TBL] [Abstract][Full Text] [Related]
14. Treatment of ankylosing spondylitis with infliximab.
Boeger CA; Wittwer H; Schattenkirchner M; Kellner H; Kellner W
Ann Rheum Dis; 2001 Dec; 60(12):1159-60. PubMed ID: 11760727
[No Abstract] [Full Text] [Related]
15. [New results from studies of therapy of ankylosing spondylitis with infliximab].
Braun J
Z Rheumatol; 2003 Apr; 62(2):108-9. PubMed ID: 12820612
[No Abstract] [Full Text] [Related]
16. [Anti-TNF alpha in the treatment of rheumatoid arthritis and ankylosing spondylitis].
Lanfant-Weybel K; Lequerré T; Vittecoq O
Presse Med; 2009 May; 38(5):774-87. PubMed ID: 19327945
[TBL] [Abstract][Full Text] [Related]
17. [The off-label-prescription of TNF-alpha blocking agents for spondyloarthropathies in the context of recent statement by a German federal court].
Sieper J
Z Rheumatol; 2002 Dec; 61(6):688-93. PubMed ID: 12491132
[TBL] [Abstract][Full Text] [Related]
18. Real-world anti-tumor necrosis factor treatment in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: cost-effectiveness based on number needed to treat to improve health assessment questionnaire.
Barra L; Pope JE; Payne M
J Rheumatol; 2009 Jul; 36(7):1421-8. PubMed ID: 19487267
[TBL] [Abstract][Full Text] [Related]
19. Novel therapies in the treatment of spondyloarthritis.
Maksymowych WP
Expert Opin Investig Drugs; 2002 Jul; 11(7):937-46. PubMed ID: 12084004
[TBL] [Abstract][Full Text] [Related]
20. [Autoimmune aspects of treatment with TNF-alpha inhibitors].
Kolarz B; Targońska-Stepniak B; Darmochwał-Kolarz D; Majdan M
Postepy Hig Med Dosw (Online); 2007 Aug; 61():478-84. PubMed ID: 17786135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]